Glazer Capital »

Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Glazer Capital

Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Glazer Capital from 13F filings

Historical chart of Glazer Capital investment in Halozyme Therapeutics Inc Note 1.000 8/1

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by Glazer Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by Glazer Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $13M 11M 1.19

More positions owned by Glazer Capital

Powerschool Holdings Com Cl A
R1 RCM (RCM)
Squarespace Class A (SQSP)
Perficient (PRFT)
Envestnet Note 2.625% 12/1/2027 (Principal)
Smartsheet Com Cl A (SMAR)
Petiq Com Cl A (PETQ)
Enstar Group SHS (ESGR)
Instructure Hldgs (INST)
Nuvei Corporation Sub Vtg Shs (NVEI)
Chuys Hldgs (CHUY)
Envestnet (ENV)
Everi Hldgs (EVRI)
Techtarget Note 12/15/2026 (Principal)
Sharecare Com Cl A (SHCR)

View all positions for Glazer Capital

Top funds holding Halozyme Therapeutics Inc Note 1.000 8/1

M&G
Citadel Advisors
MacKay Shields
Lazard Asset Management
Calamos Advisors
Polar Securities
BlackRock
Wolverine Asset Management
Ing Investment Management
Wells Fargo & Company
CNH Partners
State Street Corporation
BlackRock
Absolute Investment Advisers
Glazer Capital

View all funds holding Halozyme Therapeutics Inc Note 1.000 8/1